Exelixis
EXEL
#1826
Rank
C$16.00 B
Marketcap
C$59.68
Share price
-1.20%
Change (1 day)
19.97%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company